CLEARWATER, FL / ACCESS Newswire / March 1, 2026 / Leone Asset Management (OTCID:LEON) today announced that its wholly owned subsidiary, JP Anderson, has signed a Memorandum of Understanding (MOU) with the Jong Chiefdom covering Vaama Village in Bonthe District, Sierra Leone. This strategic agreement represents a key step in advancing the Company's rare earth mineral exploration strategy and expanding its footprint in West Africa's emerging critical minerals sector. ...

Financial Performance - Applied Optoelectronics (AOI) reported record quarterly revenue driven by high demand for its CATV and data center products [1] - The company's stock price increased by approximately 65% following the announcement of these strong financial results [1] Market Demand - There is a notable increase in demand for CATV products and data center products, indicating a positive trend in the company's core markets [1]

Group 1 - Vital Farms (VITL) is positioned as an ethical alternative to factory farms, focusing on pasture-raised eggs from small farms [1] - The company's network has expanded to 600 farms, indicating significant growth in its supply chain [1] - Despite its ethical positioning and growth, Vital Farms' stock price has experienced a decline [1]

Carine Lamercie Jean-Claude, senior vice president, chief legal officer, and secretary at Arrow Electronics (ARW 1.25%), reported the exercise of 4,078 stock options with immediate sale of the resulting shares for a total value of $652,480 on Feb. 23, 2026, according to a SEC Form 4 filing.Transaction summaryMetricValueShares traded (direct)4,078Transaction value~$652,000Post-transaction shares (direct)15,626Post-transaction value (direct ownership)~$2.49 millionTransaction value based on SEC Form 4 weighte ...

Core Viewpoint - Aviva, the U.K.'s largest insurer, has a mixed long-term performance record, with its antecedent companies existing before the establishment of the U.S.A., allowing for a historical perspective on its performance [1]. Group 1 - Aviva's long-term performance can be analyzed due to its historical background, which predates the U.S.A. [1].

What happenedAccording to a Securities and Exchange Commission (SEC) filing dated February 13, 2026, Herald Investment Management Ltd. initiated a new position in DigitalOcean Holdings (DOCN +3.32%), acquiring 202,000 shares. The estimated transaction value was $9.71 million. The quarter-end position value also stood at $9.71 million, reflecting the new holding’s valuation, including changes in stock price.What else to knowThis new position accounts for 1.27% of Herald’s reportable U.S. equity assets under ...

Company Overview - Bristol Myers Squibb is one of the world's largest pharmaceutical companies, known for its long and successful track record in a highly competitive sector with high drug development costs [2] - The company is currently focusing on cardiovascular, cancer, and immune-related medicines, which are significant healthcare opportunities, despite the market's current fascination with GLP-1 weight-loss drugs [4] Financial Performance - The stock is approximately 25% below its late 2022 highs, presenting a potential recovery opportunity alongside a dividend yield of 4%, which is above the average pharmaceutical stock yield of 1.7% [5] - The payout ratio for dividends is around 70%, indicating a sustainable dividend policy, as the company has a history of regularly increasing dividends and maintaining them during tough times [5] - Key financial metrics include a market cap of $127 billion, a gross margin of 65.89%, and a current stock price of $62.37, with a day's range of $61.18 to $62.67 [6][7] Patent and Product Pipeline - Bristol Myers Squibb's Opdivo cancer drug is set to lose patent protection in 2028, raising investor concerns; however, the company is exploring alternative delivery methods to potentially extend patent protections [7] - The company has a pipeline of other drugs in development, demonstrating its ability to manage patent expirations, which are a normal aspect of the pharmaceutical business [8] Investment Opportunity - The current market conditions present an opportunity to invest in an out-of-favor stock with a relatively high yield, allowing for potential growth through dividend reinvestment [9] - While Bristol Myers Squibb should not be the sole investment, it can serve as a strong foundation for a diversified portfolio, enabling investors to take on more risk in other areas [9]

Core Insights - Sweetgreen's performance in 2025 was significantly poor, with comparable sales declining 11.5% in Q4 and total revenue falling 3.5% to $155.2 million, missing estimates on both fronts [1][2] - The company is projecting a challenging 2026, with guidance indicating comparable sales between -2% and -4% and a restaurant-level profit margin compressing to 14.2%-14.7% [1][2] Financial Performance - In 2024, Sweetgreen experienced a 6% increase in comparable sales and reported adjusted EBITDA of $18.7 million, but the stock has since plummeted 87% from its peak in late 2024 [2] - The company finished 2025 with a same-store sales decline of 7.9% and a revenue increase of only 0.4%, indicating a significant downturn compared to other fast-casual chains [6] Challenges Faced - Factors contributing to Sweetgreen's decline include setbacks from LA wildfires and a loss of loyalty members due to a change in its subscription model [4] - The company has faced criticism regarding high food prices and poor value perception, which have negatively impacted customer loyalty [6] Strategic Moves - Sweetgreen announced the sale of its Spyce business, which includes the Infinite Kitchen automation system, to raise cash while retaining usage rights [5] - The introduction of wraps, a new menu item, is seen as a potential strategy to improve sales and address price perception issues, with initial tests underway in select locations [7][8][9] Market Outlook - Despite the challenges, Sweetgreen's stock valuation has dropped significantly, trading at a price-to-sales ratio of just 1, suggesting that the market may be underestimating the potential for recovery [11][12] - A modest improvement in 2026 could lead to a positive stock response, with wraps potentially serving as a catalyst for growth [13]

Core Viewpoint - Shares of Phillips 66 (PSX) have performed well over the past year, gaining approximately 20% due to improvements in the refining environment, despite challenges faced by its chemicals unit [1] Group 1: Company Performance - Phillips 66 has seen a 20% increase in share value over the past year [1] - The company has benefited from an improved refining environment [1] - The chemicals unit of Phillips 66 is currently struggling [1]

Core Insights - The Avantis US Large Cap Value ETF (AVLV) employs value-oriented strategies with additional profitability screens, resulting in a balanced portfolio that includes sectors such as industrials, consumer discretionary, financial services, and technology [1] Fund Strategy - The fund focuses on value investing while integrating profitability metrics to enhance portfolio balance [1]